2 days ago · Insiders have sold a total of 16,432 Verastem shares in the last 24 months for a total of $168,350.95 sold. This page (NASDAQ:VSTM) was last updated on 5/25/2024 by MarketBeat.com Staff.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. About Barinthus Bio. Our Technology.Track Sunshine Biopharma Inc (SBFM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON--(BUSINESS WIRE)--May 31, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.Verastem's stockholders approved an amendment to Verastem's Restated Certificate of Incorporation (as amended, the ...Unlike a quitclaim deed, a warranty deed transfers the ownership of a property from one person to another while guaranteeing that the title to the property is lien-free. In Texas, ...At Verastem Oncology, we're on a mission to make sure no patient ever has to hear that news. We embrace the power of partnership and collaboration to develop novel cancer therapies. It's through these collaborations that we'll bring hope to patients with RAS pathway-driven cancers. Purposeful. Unwavering. Influential. Insightful.0.49%. $84.89B. VSTM | Complete Verastem Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.For many patients with difficult-to-treat cancers, the options have been few. Verastem Oncology aims to change that by pursuing RAS pathway-targeted treatment combinations with avutometinib (VS-6766). Find out more about our clinical trials here. FIND A TRIAL. Verastem-Sponsored Trials Investigator-Sponsored Trials.Track VERSES Technologies Inc - Ordinary Shares - Class A (Sub Voting) (VRSSF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsPopular. Track Vroom Inc. (VRM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of ...Track Veritone Inc (VERI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThis means patients quickly run out of therapeutic options. At Verastem Oncology, we’re committed to ensuring options exist. For more information about the work we’re doing at Verastem Oncology, please access our Resources section or contact Julissa Viana via email at [email protected]. Press Releases. Media Kit.Synchronize with Stocktwits. Rev up your stock tracking game with STCK.PRO! With just a few clicks, you can import your watchlist from Stocktwits and get a real-time overview of all the latest news articles published on your favorite symbols! Free forever. Get started!Track Aptose Biosciences Inc (APTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is ...Mizuho Securities analyst Mara Goldstein maintained a Hold rating on Verastem (VSTM – Research Report) today and set a price target of $24.00.The company’s shares closed yesterday at $1.02 ...Get the latest Verastem Inc (VSTM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Verastem Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VSTM updated stock price target summary.Track Arm Holdings Plc. (ARM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on exploring the unexplored to give patients diagnosed with cancer better options.Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients.See the latest Verastem Inc stock price (VSTM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Track Actinium Pharmaceuticals Inc (ATNM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsWatertown, Mass. (February 7, 2024) – Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, today announced that management will participate in several upcoming investor conferences: Oppenheimer 34th Annual …Track Inspire Veterinary Partners Inc. - Ordinary Shares - Class A (IVP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsInteractive stock price chart for Verastem, Inc. (VSTM) with real-time updates, full price history, technical analysis and more.The S&P 500 tech stock index has climbed 11% year to date. Get the latest Verastem Inc. (VSTM) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.We would like to show you a description here but the site won't allow us.The latest price target for Verastem ( NASDAQ: VSTM) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 17.50 expecting VSTM to rise to within 12 ...Verastem trades at a near all-time low, so it's the perfect moment to analyze the risks and rewards of this investment. The company has a strong distribution network to sustain high growth levels ...BOSTON--(BUSINESS WIRE)--Apr. 4, 2024-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 35,000 shares of its common stock to four new employees.The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employees ...BOSTON--(BUSINESS WIRE)--Oct. 20, 2022-- Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Anil Kapur to its Board of Directors, effective October 20, 2022. Mr. Kapur is the Executive Vice President, Corporate Strategy and Chief Commercial Officer at Geron Corporation.Verastem Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VSTM updated stock price target summary.Track Aeva Technologies Inc (AEVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019–)Spirit AeroSystems Holdings, Inc. analysts consensus, targets, ratings and recommendations | Nyse: SPR | NyseJan 29, 2024 · Expect to Begin Rolling Submission of New Drug Application (NDA) for Accelerated Approval to FDA for Avutometinib and Defactinib Regimen in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) in H1 2024; Prepare for Potential Commercial Launch in 2025 Initial Data Read-Out from RAMP 205 Trial ofWhat is Verastem's stock forecast and purchase recommendation? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Verastem is $28.79, with a high forecast of $36.00 and a low forecast of $17.50. The consensus rating for Verastem stock is Buy based on the …Track Aptose Biosciences Inc (APTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (NASDAQ:VSTM) Thursday said Dan Calkins was being promoted to chief financial officer from vice president of finance. Additionally, Mike Crowther was appointed as chief ...Track Viasat, Inc. (VSAT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...Verastem Oncology VSTM announced positive interim safety and efficacy data from the dose level 1 cohort of its early to mid-stage study evaluating avutometinib and …Track Vistra Corp (VST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe latest price target for Verastem ( NASDAQ: VSTM) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 17.50 expecting VSTM to rise to within 12 ...Shares of Verastem, Inc. (NASDAQ:VSTM – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are covering the firm, Marketbeat.com reports.Six investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued …Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Read more about Verastem Oncology Outlines Key 2024 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib and Defactinib and Broader Pipeline in RAS Pathway-Driven Cancers Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung ...10.86. +3.43%. Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS/MAPK driven tumors as part of its (Raf And Mek Program). RAMP 301 (NCT06072781) is a Phase 3 ...Track Verona Pharma plc American Depositary (VRNA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Affirm Holdings Inc (AFRM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors1.9300. -1.03%. IBIOiBio, Inc. 2.1900. -1.13%. Find the latest Arbutus Biopharma Corporation (ABUS) stock quote, history, news and other vital information to help you with your stock trading and ...Seanergy Maritime Holdings Corp. analysts consensus, targets, ratings and recommendations | Nasdaq: SHIP | NasdaqBOSTON, May 23, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine and Nab ...Verastem, Inc. (VSTM) Follow. 4.1200 -8.0600 (-66.17%) At close: 4:00 PM EDT. 4.1703 +0.05 (+1.22%) After hours: 5:08 PM EDT. Conversations. Community Insights. MRUS …Need a Instagram agency in Melbourne? Read reviews & compare projects by leading Instagram marketing companies. Find a company today! Development Most Popular Emerging Tech Develop...BOSTON, May 25, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced updated data from Part A of the ...Details of the Trade. The acquisition of Verastem Inc shares by Viking Global Investors LP on December 31, 2023, marks a significant addition to the firm's portfolio. The trade, executed at $8.14 ...Synchronize with Stocktwits. Rev up your stock tracking game with STCK.PRO! With just a few clicks, you can import your watchlist from Stocktwits and get a real-time overview of all the latest news articles published on your favorite symbols! Free forever. Get started!Verastem Will Receive $70 Million Up-Front with Total Deal Value Up to $311 Million, Plus Double-Digit Sales Royalties . Upon Closing, Verastem’s Current Programs Will Be Funded Until At Least 2024 to Develop VS-6766 and Defactinib in Low-Grade Serous Ovarian Cancer and KRAS Mutant Non-Small Cell Lung Cancer . Phase …Verastem Oncology is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accurary of the information contained in the linked sites. We suggest that you always verify the information obtained ...SSR Mining Inc. analysts consensus, targets, ratings and recommendations | Toronto S.E.: SSRM | Toronto S.E.The forward-looking statements contained in this press release reflect Verastem Oncology’s views as of the date hereof, and Verastem Oncology does not assume and specifically disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.At Verastem Oncology, we're working every day to make sure they don't. By embracing the power of external partnerships and collaboration, we're putting our collective knowledge and expertise to work to deliver novel treatment approaches that address areas of high unmet need in RAS pathway-driven cancers. Patients desperately need better ...Track Castellum Inc (CTM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem press release (VSTM): Q1 Non-GAAP EPS of -$0.09.Verastem Oncology ended the first quarter of 2023 with cash, cash equivalents and investments of $111.2 million.Shares -4% AH.Goldman Sachs Adjusts Price Target on DISH Network to $3 From $6, Maintains Neutral Rating. Nov. 09. MT. Deutsche Bank Cuts DISH Network Price Target to $10 From $15, Maintains Buy Rating. Nov. 08. MT. UBS Cuts DISH Network Price Target to $4 From $9, Maintains Neutral Rating. Nov. 07.Track Vertex Pharmaceuticals, Inc. (VRTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON, January 18, 2024--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the U.S. Food and Drug ...Verastem is currently enrolling KRAS G12C inhibitor-resistant and naïve KRAS G12C-mutant NSCLC patients in the expansion phase of the RAMP 203 study. Updated results from the study are expected ...We would like to show you a description here but the site won't allow us.Verastem Oncology (Verastem Inc) is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. History. Verastem ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...By Karl Utermohlen, InvestorPlace Writer Dec 15, 2017. DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.Adage Capital Partners GP L.L.C. raised its position in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) by 116.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,300,000 shares of the biopharmaceutical company's stock after buying an ad.BOSTON, March 11, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced multiple oral and poster ...Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition.Company ended Q3 2023 with $21.3 million GAAP operating expenses and $19.8 million non-GAAP operating expenses* 3. * Q3 2023 GAAP operating expenses - $21.31M less Q3 2023 stock compensation of $1.52M = $19.79M Q3 2023 non-GAAP operating expenses.Verastem Will Receive $70 Million Up-Front with Total Deal Value Up to $311 Million, Plus Double-Digit Sales Royalties . Upon Closing, Verastem's Current Programs Will Be Funded Until At Least 2024 to Develop VS-6766 and Defactinib in Low-Grade Serous Ovarian Cancer and KRAS Mutant Non-Small Cell Lung Cancer . Phase 2 Registration-Directed Trials Expected to Commence by Year End 2020 in Both ...BBG001J2LSK5. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered ...New Data from Interim Analysis of Verastem Oncology's RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) to be Presented at the American Society of Clinical Oncology Annual Meeting. Studies of Avutometinib Combinations in KRAS G12C Mutant Non-Small Lung Cancer, Pancreatic Cancer and Other RAS Pathway-Driven Cancers AdvancingVerastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival .... Track CAVA GROUP INC (CAVA) Stock Price, Quote, latest communitThe stock options have an exercise price equal to $7.6 10.86. +3.43%. Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued. Get the latest Verastem Inc (VSTM) real-time quote, historical Track NVIDIA Corp (NVDA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Verastem (VSTM) gains 57% post-market on achieving...
Continue Reading